No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs7734352 |
chr5:147648510-147648511 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs140717841 |
chr5:147648534-147648535 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs574448190 |
chr5:147648553-147648554 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs145855103 |
chr5:147648556-147648557 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs576321054 |
chr5:147648577-147648578 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs115597309 |
chr5:147648675-147648676 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs555867581 |
chr5:147648694-147648695 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs560255036 |
chr5:147648698-147648699 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs181014495 |
chr5:147648705-147648706 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs541577154 |
chr5:147648711-147648712 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs138321621 |
chr5:147648734-147648735 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs7733564 |
chr5:147648750-147648751 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs527488250 |
chr5:147648761-147648762 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs79126418 |
chr5:147648832-147648833 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs149626126 |
chr5:147648901-147648902 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs531613715 |
chr5:147648911-147648912 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs200767838 |
chr5:147648942-147648943 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs531412846 |
chr5:147648946-147648947 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs186423074 |
chr5:147648950-147648951 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs529257480 |
chr5:147648952-147648953 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs200316981 |
chr5:147648960-147648961 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs545639741 |
chr5:147648961-147648962 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs564030956 |
chr5:147648986-147648987 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs1347115 |
chr5:147649030-147649031 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
25 |
rs565797223 |
chr5:147649055-147649056 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs539687406 |
chr5:147649118-147649119 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs561657159 |
chr5:147649145-147649146 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs557929633 |
chr5:147649147-147649148 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs192045675 |
chr5:147649152-147649153 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs17108103 |
chr5:147649181-147649182 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
31 |
rs371032900 |
chr5:147649193-147649194 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs547775592 |
chr5:147649273-147649274 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs181756939 |
chr5:147649274-147649275 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs541763666 |
chr5:147649352-147649353 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs367672291 |
chr5:147649365-147649366 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs553948628 |
chr5:147649385-147649386 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs572167545 |
chr5:147649395-147649396 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs11435083 |
chr5:147649398-147649399 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs537672268 |
chr5:147649399-147649400 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs568382771 |
chr5:147649404-147649405 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs574314014 |
chr5:147649408-147649409 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs546048424 |
chr5:147649412-147649413 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs564257785 |
chr5:147649475-147649476 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs531496848 |
chr5:147649480-147649481 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs552465998 |
chr5:147649491-147649492 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs561969193 |
chr5:147649500-147649501 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs370523345 |
chr5:147649503-147649504 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs56306866 |
chr5:147649509-147649510 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs186617788 |
chr5:147649520-147649521 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs547763255 |
chr5:147649539-147649540 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|